Tm Biosciences Closes $CA12M Private Placement

genomeweb
360dx

Tm Biosciences Closes $CA12M Private Placement

Dec 22, 2003

NEW YORK, Dec. 22 (GenomeWeb News) - Tm Biosciences of Toronto said today it had closed a $CA12 million ($9 million) private placement

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Genome of Medieval Relapsing Fever Pathogen Provides Insights Into Microbe's Evolution
Genetics, Gut Microbes Linked to Blood Levels of Cardiovascular Disease-Related Proteins
NIH Expanding Undiagnosed Disease Network With New Grants
GeneCentric Licenses UNC Pancreatic Cancer Subtyping Tech
OpGen Partners With NYS DOH, Merck Subsidiary for Antimicrobial Resistance Surveillance
Top Five Articles on GenomeWeb Last Week: Qiagen, Premaitha, Roche, and More

The Scan

To Control the Spread

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

More to Do

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

This Week in PLOS

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

'Follow Me to Maryland'

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.

Main menu